Cyclin E2, the cycle continues

被引:45
作者
Payton, M [1 ]
Coats, S [1 ]
机构
[1] Amgen Inc, Dept Canc Biol, Thousand Oaks, CA 91320 USA
关键词
cyclin E; cyclin E2; CDK2;
D O I
10.1016/S1357-2725(01)00137-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The eukaryotic cell cycle is regulated by a family of serine/threonine protein kinases known as cyclin-dependent kinases (CDKs). The activation of a CDK is dependent on its association with a cyclin regulatory subunit. The formation of distinct cyclin-CDK complexes controls the progression through the first gap phase (G(1)) and initiation of DNA synthesis (S phase). These complexes are in turn regulated by protein phosphorylation and cyclin-dependent kinase inhibitors (CKIs). Cyclin E2 has emerged as the second member of the E-type cyclin family. Cyclin E2-associated kinase activity is regulated in a cell cycle dependent manner with peak activity at the G(1) to S transition. Ectopic expression of cyclin E2 in human cells accelerates G(1), suggesting that cyclin E2 is rate limiting for G, progression. Although the pattern and level of cyclin E2 expression in some primary tumor and normal tissue RNAs are distinct from cyclin El, both E-type cyclins appear to have inherent functional redundancies. This functional redundancy has facilitated the rapid characterization of cyclin E2 and uncovered unique features associated with each E-type cyclin. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 27 条
[1]  
BORTNER DM, 1997, MOL CELL BIOL, V17, P45
[2]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[3]   The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts [J].
Cheng, MG ;
Olivier, P ;
Diehl, JA ;
Fero, M ;
Roussel, MF ;
Roberts, JM ;
Sherr, CJ .
EMBO JOURNAL, 1999, 18 (06) :1571-1583
[4]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[5]   Cyclin E in human cancers [J].
Donnellan, R ;
Chetty, R .
FASEB JOURNAL, 1999, 13 (08) :773-780
[6]   Rescue of cyclin D1 deficiency by knockin cyclin E [J].
Geng, Y ;
Whoriskey, W ;
Park, MY ;
Bronson, RT ;
Medema, RH ;
Li, TS ;
Weinberg, RA ;
Sicinski, P .
CELL, 1999, 97 (06) :767-777
[7]  
Gudas JM, 1999, MOL CELL BIOL, V19, P612
[8]   Interactions of the human papillomavirus E7 protein with cell cycle regulators [J].
Jones, DL ;
Munger, K .
SEMINARS IN CANCER BIOLOGY, 1996, 7 (06) :327-337
[9]   Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein [J].
Kelly, BL ;
Wolfe, KG ;
Roberts, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2535-2540
[10]  
KEYOMARSI K, 1994, CANCER RES, V54, P380